Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities
Net loss	$ (7,823,453)	$ (580,216)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	211,658	24,786
Stock based compensation, including amortization of prepaid fees	307,160	118,257
Amortization of original issue discount and debt discount on convertible notes		292,163
Change in fair value of derivative financial instruments		(733,734)
Loss on extinguishment of debt	5,589,994	467,937
Change in fair value of debt	19,246	(35,965)
Change in fair value of contingent acquisition consideration	635,700
Changes in operating assets and liabilities:
Accounts receivable	(38,152)	9,090
Inventory	(16,202)	(19,141)
Prepaid expenses and deposits	4,032	62,562
ROU lease assets	24,234	80,760
Accounts payable and accrued expenses	(83,854)	(10,556)
Lease liability	(24,956)	(76,236)
Due to related party, current portion		16,106
Contract liabilities	(22,366)
Net cash used in operating activities	(1,216,959)	(384,187)
Cash Flows from Investing Activities
Acquisition of property and equipment	(7,399)
Net cash provided by investing activities	(7,399)
Cash Flows from Financing Activities
Proceeds from sale of common stock	4,389,361	437,433
Proceeds from exercise of options and warrants	65,650
Proceeds from issuance of convertible notes		344,000
Repayment of convertible notes		(373,094)
Proceeds from related party loans		149,000
Repayment of related party loans		(79,327)
Repayment of notes payable	(51,109)
Net cash provided by financing activities	4,403,902	478,012
Net increase in cash	3,179,544	93,825
Cash, beginning of period	162,184	110,441
Cash, end of period	3,341,728	204,266
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	232	15,016
Cash paid during the period for income tax
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable		72,890
Common stock issuable issued during period	66,161	66,175
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	126,502
Conversion of convertible note payable to common shares	4,061,549	652,560
Fair value of warrants issued in connection with conversion of convertible notes payable	3,074,637
Accrued liabilities relieved upon cashless exercise of warrants	614,221
Adoption of lease obligation and ROU asset		43,297
Derivative liabilities written off with repayment of convertible notes payable		51,798
Derivative liabilities written off with conversion of convertible notes payable		52,087
Reduction in contingent acquisition consideration		$ 200,328